Alternatives to BenevolentAI

SciSpace BioMed Agent runs multi-omics, variant prioritization, and drug repurposing analysis from plain-language biomedical prompts.

AI-native drug discovery company pairing 20+ petabytes of cellular data with human genetics to find causal disease targets

Generative AI drug discovery suite spanning target ID, molecule design, biologics and clinical trial prediction.

AI drug discovery built on Recursion OS: 2M weekly wet-lab experiments feeding a 50+ PB dataset, with Exscientia now folded in.

Physics-based molecular simulation and AI for drug discovery and materials design.

AI-CRISPR target discovery platform pairing AlgenCRISPR gene modulation with the AlgenBrain foundation model for causal immunology and

Evotec is a life-science partner running AI-assisted drug discovery and Just–Evotec Biologics manufacturing.

Open-source, self-hosted AI research assistant for drug discovery — molecular property prediction, virtual screening and PK/PD modeling on your own hardware.

Owkin pairs K Pro, an autonomous AI scientist, with 25 million patients' data across 840 hospitals and wet lab validation for drug R&D

Nimbus Therapeutics designs highly selective small-molecule drugs for oncology, immunology, and metabolic disease.

Cellbyte gives pharma Pricing & Market Access teams source-linked HTA and pricing answers in minutes, not weeks.

Oncology real-world evidence built from point-of-care data, with AI-driven insights across a global database of six million+ patients.

AI-native pharma company using autonomous agents to find new uses for existing drugs and predict patient drug response

Project-based AI biopharma team that delivers decision-grade research, analysis, and computational design in 3–5 days.

Nanograb designs peptide-LNP targeting systems with biophysics-informed AI so genetic medicines reach a chosen cell type instead of the

Cloud R&D platform combining ELN, LIMS, automation, and agent-driven Science Foundries for biotech.

Dotmatics pairs an agentic scientific intelligence platform with Luma Agent for governed R&D data analysis.

AI drug discovery from Isomorphic Labs: predictive and generative models that design molecules and forecast drug performance.

AI protein engineering platform that designs optimized variant plates and learns from every wet-lab round.

NovaFlow is an AI data analyst for biology labs that turns raw sequencing output into cited, publication-ready results.

Delineate assembles clinical pharmacology evidence into MBMA databases and models for dose optimization and go/no-go decisions.

Open-source Python framework that assembles causal and mechanistic models from literature and biological databases.

Iktos pairs generative AI for small-molecule design with AI retrosynthesis and an autonomous robotic DMTA lab.

Cellino's AI-guided optical bioprocessing platform brings patient-specific cell therapy manufacturing to the hospital.

Iambic Therapeutics pairs Enchant v3 and NeuralPLexer AI drug discovery models with a weekly wet lab and a wholly owned clinical pipeline.

Automated cloud lab for protein validation — binding, expression and thermostability assays with data back in as little as 3 days

HealthKey uses AI patient identification to scan your EHR daily and surface trial-eligible patients for clinical research.

Haplotype Labs builds SaaS and community tooling for population genetics, aiming to cut sequencing costs 50–90% and speed polygenic risk modeling.

Frekils is AI agents for real-world evidence studies — cohorts, SAPs and publication-ready statistics on your own clinical data.

Clinician-centered clinical trial matching that notifies your patients when a local, medically relevant study exists.